ORBi: Clemmesen B - A 2-year phase II study with 1-year of follow-up of risedronate (NE58095) in postmenopausal osteoporosis

Reference : A 2-year phase II study with 1-year of follow-up of risedronate (NE58095) in postmenopau...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : General & internal medicine
	To cite this reference:	http://hdl.handle.net/2268/136095

Title :	A 2-year phase II study with 1-year of follow-up of risedronate (NE58095) in postmenopausal osteoporosis
Language :	English
Author, co-author :	Clemmesen, B []
	Ravn, P []
	Zegels, Brigitte [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
	Taquet, AN []
	Christiansen, C []
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Publication date :	1997
Journal title :	Osteoporosis International
Publisher :	Springer Science & Business Media B.V.
Volume :	7
Pages :	488-495
Peer reviewed :	Yes (verified by ORBi)
Audience :	International
ISSN :	0937-941X
e-ISSN :	1433-2965
City :	Godalming
Country :	United Kingdom
Permalink :	http://hdl.handle.net/2268/136095

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	A 2-year phase II study with 1-year of follow-up of risedronate in postmenopausal osteoporosis.pdf		Publisher postprint	741.07 kB	Request copy

All documents in ORBi are protected by a user license.